Company intelligence / Profile preview

Pathway Medical Technologies

Kirkland, Washington, United Statesforbion.com ↗

Ownership: Private
Development stage: Commercial

Overview

Pathway Medical Technologies developed and commercialized innovative medical devices for minimally invasive treatment of peripheral arterial disease. Its flagship product, the Jetstream Atherectomy System, was designed to remove both hard and soft plaque from peripheral arteries using differential cutting technology. The company achieved commercialization prior to its strategic acquisition by MEDRAD, a subsidiary of Bayer HealthCare, in September 2011. It was an innovator in minimally invasive vascular intervention devices with a focus on treating peripheral artery disease through their Jetstream Atherectomy System.

Therapeutic areas: Cardiovascular
Modalities: DeviceMechanical Atherectomy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Pathway Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathway Medical Technologies.

Explore the full profile